Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4586042
Max Phase: Preclinical
Molecular Formula: C24H34BrFN6O5
Molecular Weight: 585.48
Molecule Type: Unknown
Associated Items:
ID: ALA4586042
Max Phase: Preclinical
Molecular Formula: C24H34BrFN6O5
Molecular Weight: 585.48
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(C)[C@H](NC(=O)c1ccc(Br)cc1)C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)CF
Standard InChI: InChI=1S/C24H34BrFN6O5/c1-13(2)20(31-21(35)14-5-7-15(25)8-6-14)23(37)32-12-16(33)10-18(32)22(36)30-17(19(34)11-26)4-3-9-29-24(27)28/h5-8,13,16-18,20,33H,3-4,9-12H2,1-2H3,(H,30,36)(H,31,35)(H4,27,28,29)/t16-,17+,18+,20+/m1/s1
Standard InChI Key: ZHDIHIZTRHGAAP-LXZJYRNTSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 585.48 | Molecular Weight (Monoisotopic): 584.1758 | AlogP: 0.45 | #Rotatable Bonds: 12 |
Polar Surface Area: 177.71 | Molecular Species: BASE | HBA: 6 | HBD: 6 |
#RO5 Violations: 2 | HBA (Lipinski): 11 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 12.51 | CX Basic pKa: 11.88 | CX LogP: -0.04 | CX LogD: -2.12 |
Aromatic Rings: 1 | Heavy Atoms: 37 | QED Weighted: 0.12 | Np Likeness Score: -0.12 |
1. Hatcher JM, Du G, Fontán L, Us I, Qiao Q, Chennamadhavuni S, Shao J, Wu H, Melnick A, Gray NS, Scott DA.. (2019) Peptide-based covalent inhibitors of MALT1 paracaspase., 29 (11): [PMID:30954428] [10.1016/j.bmcl.2019.03.046] |
Source(1):